LV10455B - A process for the preparation of 9-substituted guanine derivatives and intermediates for use in the process - Google Patents

A process for the preparation of 9-substituted guanine derivatives and intermediates for use in the process Download PDF

Info

Publication number
LV10455B
LV10455B LVP-92-250A LV920250A LV10455B LV 10455 B LV10455 B LV 10455B LV 920250 A LV920250 A LV 920250A LV 10455 B LV10455 B LV 10455B
Authority
LV
Latvia
Prior art keywords
vas
amino
imidazole
formula
carboxamide
Prior art date
Application number
LVP-92-250A
Other languages
English (en)
Latvian (lv)
Other versions
LV10455A (lv
Inventor
Alhede Borge Ingvar Frisch
Clausen Finn Priess
Juhl-Christensen Jorgen
Klaus K Mccluskey
Preikschat Herbert
Original Assignee
Gea Farmaceutisk Fabrik As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gea Farmaceutisk Fabrik As filed Critical Gea Farmaceutisk Fabrik As
Publication of LV10455A publication Critical patent/LV10455A/xx
Publication of LV10455B publication Critical patent/LV10455B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/18—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one nitrogen atom, e.g. guanine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/052—Imidazole radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
LVP-92-250A 1989-03-20 1992-12-02 A process for the preparation of 9-substituted guanine derivatives and intermediates for use in the process LV10455B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK135489A DK135489D0 (da) 1989-03-20 1989-03-20 Fremgangsmaade til fremstilling af 9-substituerede guaninderivater og mellemprodukter til brug ved fremgangsmaaden
PCT/DK1990/000077 WO1990011283A1 (en) 1989-03-20 1990-03-19 A process for the preparation of 9-substituted guanine derivatives and intermediates for use in the process

Publications (2)

Publication Number Publication Date
LV10455A LV10455A (lv) 1995-02-20
LV10455B true LV10455B (en) 1995-08-20

Family

ID=8103930

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-92-250A LV10455B (en) 1989-03-20 1992-12-02 A process for the preparation of 9-substituted guanine derivatives and intermediates for use in the process

Country Status (28)

Country Link
US (1) US5223619A (no)
EP (1) EP0464112B1 (no)
KR (1) KR0142098B1 (no)
AR (1) AR245719A1 (no)
AT (1) ATE112568T1 (no)
BG (1) BG60590B1 (no)
BR (1) BR9007230A (no)
CA (1) CA2047217A1 (no)
CS (1) CS9001365A3 (no)
DD (1) DD293116A5 (no)
DE (1) DE69013146T2 (no)
DK (2) DK135489D0 (no)
ES (1) ES2061023T3 (no)
FI (1) FI97387C (no)
GE (1) GEP19971014B (no)
GR (1) GR1001096B (no)
HR (1) HRP920907B1 (no)
HU (1) HU206715B (no)
IE (1) IE62042B1 (no)
LT (1) LT3183B (no)
LV (1) LV10455B (no)
NO (1) NO178497C (no)
PL (1) PL163313B1 (no)
RO (1) RO109737B1 (no)
RU (2) RU2090566C1 (no)
SI (1) SI9010545A (no)
WO (1) WO1990011283A1 (no)
YU (1) YU47343B (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1264599B1 (it) * 1993-06-14 1996-10-04 Solar Chem Sa Processo per la sintesi della 9-(2-idrossietossimetil)- guanina
GB9520364D0 (en) * 1995-10-05 1995-12-06 Chiroscience Ltd Compouundds
US6872243B2 (en) 2002-09-04 2005-03-29 Xerox Corporation Phase change inks containing gelator additives
US6811595B2 (en) 2002-09-04 2004-11-02 Xerox Corporation Guanidinopyrimidinone compounds and phase change inks containing same
US6761758B2 (en) 2002-09-04 2004-07-13 Xerox Corporation Alkylated tetrakis(triaminotriazine) compounds and phase change inks containing same
US6860928B2 (en) 2002-09-04 2005-03-01 Xerox Corporation Alkylated urea and triaminotriazine compounds and phase change inks containing same
US7317122B2 (en) 2004-12-04 2008-01-08 Xerox Corporation Curable trans-1,2-cyclohexane bis(urea-urethane) compounds
US7314949B2 (en) 2004-12-04 2008-01-01 Xerox Corporation Trans-1,2-cyclohexane bis(urea-urethane) compounds
US7144450B2 (en) 2004-12-04 2006-12-05 Xerox Corporation Phase change inks containing trans-1,2-cyclohexane bis(urea-urethane) compounds
US7153349B2 (en) 2004-12-04 2006-12-26 Xerox Corporation Phase change inks containing curable trans-1,2-cyclohexane bis(urea-urethane) compounds
US7560587B2 (en) 2004-12-04 2009-07-14 Xerox Corporation Bis[urea-urethane] compounds
US7220300B2 (en) 2004-12-04 2007-05-22 Xerox Corporation Phase change inks containing bis(urea-urethane) compounds
CN105705284B (zh) 2013-10-29 2019-05-31 舒瑞普国际股份公司 使用丝网印刷钎焊材料钎焊板式换热器的方法；利用该方法制造的板式换热器
CN115504977B (zh) * 2022-09-23 2024-02-09 海南锦瑞制药有限公司 更昔洛韦的制备方法及注射用更昔洛韦的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56152437U (no) * 1980-04-14 1981-11-14
US4451478A (en) * 1982-03-12 1984-05-29 Newport Pharmaceuticals International, Inc. Imidazole compounds
US4602089A (en) * 1982-03-12 1986-07-22 Newport Pharmaceuticals, Inc. Process for preparing purine compounds
JPS6055071B2 (ja) * 1982-04-16 1985-12-03 四国化成工業株式会社 イミダゾリル琥珀酸化合物および該化合物を用いるエポキシ樹脂硬化方法
HUT36464A (en) * 1983-05-24 1985-09-30 Newport Pharmaceuticals Process for producing erythro-4-amino-3-/2-hydroxy-3-alkyl/-imidazol-5-carboxamide
EP0219838A3 (en) * 1985-10-22 1988-04-06 Takeda Chemical Industries, Ltd. Carbocyclic purine nucleosides, their production and use
MY101126A (en) * 1985-12-13 1991-07-31 Beecham Group Plc Novel compounds

Also Published As

Publication number Publication date
US5223619A (en) 1993-06-29
BG95145A (bg) 1993-12-24
BG60590B1 (en) 1995-09-29
IE900994L (en) 1990-09-20
PL163313B1 (pl) 1994-03-31
FI914418A0 (fi) 1991-09-19
SI9010545A (en) 1997-08-31
YU47343B (sh) 1995-01-31
DE69013146D1 (de) 1994-11-10
IE62042B1 (en) 1994-12-14
RU2042668C1 (ru) 1995-08-27
DK0464112T3 (da) 1995-03-13
LT3183B (en) 1995-03-27
NO913686D0 (no) 1991-09-19
HU206715B (en) 1992-12-28
ES2061023T3 (es) 1994-12-01
DK135489D0 (da) 1989-03-20
AR245719A1 (es) 1994-02-28
GR1001096B (el) 1993-04-28
KR0142098B1 (ko) 1998-06-01
GEP19971014B (en) 1997-04-18
RO109737B1 (ro) 1995-05-30
LTIP297A (en) 1994-08-25
NO178497B (no) 1996-01-02
NO178497C (no) 1996-04-10
GR900100212A (en) 1990-07-31
BR9007230A (pt) 1992-02-25
HUT59141A (en) 1992-04-28
NO913686L (no) 1991-09-19
HRP920907B1 (en) 1998-06-30
FI97387C (fi) 1996-12-10
CA2047217A1 (en) 1990-09-21
HRP920907A2 (hr) 1994-04-30
HU902874D0 (en) 1991-12-30
FI97387B (fi) 1996-08-30
CS275359B2 (en) 1992-02-19
LV10455A (lv) 1995-02-20
DD293116A5 (de) 1991-08-22
CS9001365A3 (en) 1992-02-19
KR920701208A (ko) 1992-08-11
WO1990011283A1 (en) 1990-10-04
ATE112568T1 (de) 1994-10-15
RU2090566C1 (ru) 1997-09-20
EP0464112A1 (en) 1992-01-08
EP0464112B1 (en) 1994-10-05
DE69013146T2 (de) 1995-02-16
YU54590A (sh) 1992-12-21

Similar Documents

Publication Publication Date Title
FI96513C (fi) Menetelmä terapeuttisesti aktiivisten ksantiinijohdannaisten valmistamiseksi
LV10455B (en) A process for the preparation of 9-substituted guanine derivatives and intermediates for use in the process
DE69229492T2 (de) Verfahren zur Herstellung von azyklischen Nukleosiden
IE872191L (en) Pyrimidines
US3463850A (en) Arabinofuranosyl 2-thiopyrimidines and pharmaceutical compositions thereof
EP0688782A1 (en) Stereoselective process for preparing protected 2',2'-difluorolactonen
US5942617A (en) Process for producing purine derivatives
US5041543A (en) Nucleoside and use thereof
EP0544210B1 (de) Verfahren zur Herstellung von in 5-Stellung substituierten Cytosinen und anderen 4,5-disubstituierten Pyrimidin-2(1H)-onen, sowie dabei auftretende Zwischenprodukte
US4751293A (en) Process for preparation of N6 -substituted 3',5'-cyclic adenosine monophosphate and salt thereof
US3853850A (en) Crystalline complex of penicillin g 1(s)-oxide and process for preparing same
US3412093A (en) New adenine derivatives and method for their preparation
Chu et al. Acyclopyrimidine C‐nucleosides: Synthesis of 5‐[(2, 3‐dihydroxy‐1‐propoxy) methyl] pyrimidines
EP0066440B1 (en) Chemical process
HU198179B (en) Process for producing n-methyl-1-alkylthio-2-nitroethenamine derivatives
HU203553B (en) New process for producing oxetanocin g
US5164500A (en) Oxetanocin G
US5231174A (en) 2'isodideoxy-β-D-nucleosides as stable antiviral agents
KR960011779B1 (ko) 세팔로스포린 결정성 수화물의 신규 제조방법
CA1330989C (en) 2'-2'-difluoronucleosides
IL102144A (en) Process for the preparation of '2 - deoxy -' 2, '2 - difluoro nucleosides
HU197891B (en) Process for producing basic thioether and its salt